Von Willebrand disease diagnostic study of choice

Jump to navigation Jump to search

Von Willebrand disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Von Willebrand disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Von Willebrand disease diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Von Willebrand disease diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Von Willebrand disease diagnostic study of choice

on Von Willebrand disease diagnostic study of choice

Von Willebrand disease diagnostic study of choice in the news

Blogs on Von Willebrand disease diagnostic study of choice

Directions to Hospitals Treating Von Willebrand disease

Risk calculators and risk factors for Von Willebrand disease diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Diagnostic Study of Choice

Study of choice

There is no single diagnostic study of choice for the diagnosis of von Willebrand disease , but von Willebrand disease can be diagnosed based on screening tests followed by confirmatory tests.

The following screening tests for VWD are selected by the National Heart, Lung, and Blood Institute[1]

  • VWD screening tests
    • (VWF:Ag) VWF antigen
    • (VWF:RCo) VWF ristocetin cofactor activity
    • (FVIII:C) factor 8 clotting activity

When one of the VWD screening test is abnormal, the following tests should be performed.[1]

  • VWD Confirmatory Tests
    • VWF multimer distribution
    • (VWF:CB) VWF collagen binding
    • (VWF:PB) VWF platelet binding
    • (LD-RIPA) low-dose ristocetin-induced platelet aggregation
    • (VWF) FVIIIB
    • (VWFpp) VWF propeptide
    • VWF gene sequencing
Diagnostic results

The following findings on performing VWD tests are confirmatory for von willebrand disease

VWD Screening Tests
 VWF:Ag
  • ↓ in type 1,
  • ↓ most type 2
  • Undetectable in type 3
 VWF:RCo
  • ↓ in type 1
  • ↓↓ most type 2
  • Undetectable in type 3
 FVIII:C
  • ↓ or normal in type 1
  • ↓ most type 2
  • ↓↓ in type 2N and type 3
 VWF:RCo/VWF:Ag ratio
  • ↓ in type 2A, 2B, 2M
VWD Confirmatory Tests
 VWF multimer distribution Abnormal in type 2A and type 2B
 VWF:CB Abnormal in type 2A and type 2B, some type 2M
 VWF:PB ↑ in type 2B
 LD-RIPA ↑ in type 2B and platelet-type VWD
 VWF:FVIIIB ↓ in type 2N
 VWFpp ↑ VWFpp/VWF:Ag ratio in type 1C
 VWF gene sequencing Most helpful in type 2 variants

VWF:Ag VWF antigen; VWF:RCo VWF ristocetin cofactor activity; FVIII:C factor 8 activity; VWF:CB VWF collagen binding LD-RIPA low-dose ristocetin-induced platelet aggregation; VWFpp VWF propeptide;

Sequence of Diagnostic Studies

The [name of investigation] must be performed when:

  • The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
  • A positive [test] is detected in the patient, to confirm the diagnosis.

OR

The various investigations must be performed in the following order:

  • [Initial investigation]
  • [2nd investigation]

Name of Diagnostic Criteria

It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.

[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].

OR

There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].

OR

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

[Disease name] may be diagnosed at any time if one or more of the following criteria are met:

  • Criteria 1
  • Criteria 2
  • Criteria 3

OR

IF there are clear, established diagnostic criteria

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

IF there are no established diagnostic criteria

There are no established criteria for the diagnosis of [disease name].

References

  1. 1.0 1.1 Roberts JC, Flood VH (May 2015). "Laboratory diagnosis of von Willebrand disease". Int J Lab Hematol. 37 Suppl 1: 11–7. doi:10.1111/ijlh.12345. PMC 5600156. PMID 25976955.

Template:WH Template:WS